SEC Tracker
Get the app

Traws Pharma TRAW

Traws Pharma files S-1 for stock offering

Securities offering

Form
S-1
Filed
Importance
Notable
  1. Up to 135,135,135 shares of common stock
  2. Roth Principal Investments as selling stockholder
  3. Potential gross proceeds up to $50M

Written from the S-1 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Traws Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Mannatech MTEX public float $10M, Jun 30, 2025
  2. LeonaBio ATHA public float $10M, Jun 30, 2025
  3. BioCardia BCDA public float $10M, Jun 30, 2025
  4. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025
  5. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025